News specialist portal
"Berlin - PCR testing remains the gold standard for the detection of Sars-CoV-2, and Medsan has launched a mobile point-of-care solution for the simultaneous determination of numerous swab samples. The BioeXsen ultra-RT-PCR device can test up to 180 samples within 30 minutes. Dr. Thomas Wüstefeld, CEO of Medsan, is well aware of the advantages of PCR. In contrast to the rapid antigen test, the so-called Ct value is determined here; with the help of this value, statements can be made about how infectious a person is."